Search
Close this search box.

Clinical Trial: ECOG-ACRIN NHLBI-MDS

ECOG-ACRIN NHLBI-MDS

Status: Open

The National Myelodysplastic Syndromes (MDS) Study

Eligible for screening study DCP 001

This protocol has additional regulatory requirements to be completed prior to registering any patients at your site.  Please contact Amber Boerner at 406-969-6066 or aboerner@mtcancer.org for additional information.

NHLBI-MDS is nearing accrual goal and will be closed to accrual effective June 24, 2024 at 5:00 PM ET.